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In anticipation of licensure and introduction of rotavi-
rus vaccine into the western market, we used modeling of 
national hospital registry data to determine the incidence 
and direct medical costs of annual rotavirus-associated ad-
missions over >11 years in Denmark. Diarrhea-associated 
hospitalizations coded as nonspeciﬁ   ed viral or presumed 
infectious have demonstrated a marked winter peak similar 
to that of rotavirus-associated hospitalizations, which sug-
gests that the registered rotavirus-coded admissions are 
grossly underestimated. We therefore obtained more real-
istic estimates by 2 different models, which indicated ≈2.4 
and ≈2.5 (for children <5 years of age) and ≈4.9 and ≈5.3 
(for children <2 years of age) rotavirus-associated admis-
sions per 1,000 children per year, respectively. These ad-
missions amount to associated direct medical costs of US 
$1.7–1.8 million per year. Using 2 simple models to analyze 
readily available hospital discharge data resulted in more 
consistent and  reliable estimates.
R
otavirus is the main cause of acute, severe, dehydrating 
diarrhea in infants and children throughout the world 
(1). Rotavirus disease incidence is similar worldwide, re-
gardless of infrastructure and other levels of development 
(2), which suggests that traditional diarrheal disease con-
trol measures, such as safe water and improved hygienic 
standards, are inadequate. In industrialized counties, hospi-
talizations are often the most costly events associated with 
rotavirus disease and often constitute a major expense for 
national health budgets (3). 
A recent outbreak of rotavirus diarrhea in a daycare 
center in Denmark demonstrated that even small outbreaks 
of rotavirus in childcare facilities can be associated with 
substantial expense on a personal and a public scale due to 
parental loss of work (4). A major strategy for control of 
rotavirus disease is prevention through vaccination. With 2 
new rotavirus vaccine candidates almost ready for market-
ing (5), valid and updated data on rotavirus disease extent 
and circulating rotavirus strains are essential for several 
purposes: to address the need for disease prevention, to 
generate reliable data for vaccine cost-beneﬁ  t/effective-
ness assessments, and to establish a platform for disease 
surveillance to monitor the effectiveness of a future vac-
cine program.
Because the immediate focus for development of ro-
tavirus vaccines has mainly been prevention of associated 
deaths in Asia and Africa, valid data exist to some extent 
from prospective disease surveillance studies in these re-
gions. However, despite the considerable problems associ-
ated with hospitalization, including nosocomial transmis-
sion of rotavirus disease (6,7) and the cost of parental loss 
of work (8), few data exist regarding the epidemiologic fea-
tures of rotavirus infection in industrialized countries.
For this study we used Danish National Patient Reg-
istry (NPR) data for all hospital admissions in Denmark 
since 1977 to address the epidemiology and cost of rota-
virus hospitalizations in Denmark. On the basis of ﬁ  nd-
ings from other studies of rotavirus disease (9,10), we 
anticipated an underreporting of rotavirus among patients 
hospitalized with diarrhea. This underreporting is due to 
various factors, the most important of which seems to be 
that rotavirus testing is routinely conducted in only a few 
settings because the same therapy, regardless of test re-
sults, is prescribed: symptomatic treatment with ﬂ  uid re-
placement. Therefore, testing is used mostly for differen-
tial diagnostic purposes or to establish a diagnosis during 
outbreaks or for immunocompromised persons for whom 
rapid intervention against other diarrhea agents (bacteria, 
parasites) is crucial. Also, rotavirus laboratory results of-
ten are available only after the average diarrhea patient 
has already been discharged, so these results rarely get 
recorded in the patient’s medical ﬁ  le.
The issue of underreporting is supported by a study 
in a major county hospital in Copenhagen, Denmark. The 
ﬁ  ndings suggest that among children 3–36 months of age, 
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rotavirus was responsible for ≈60% of all admissions due 
to diarrhea from December 1998 through May 1999 (11). 
In Denmark, rotavirus-associated hospitalizations occur 
with a marked seasonality, from January to June, and peak 
in March and April. So far, no other diarrhea-associated 
microbial agent with a similar seasonal pattern has been 
identiﬁ  ed. We took advantage of the unique seasonality 
of rotavirus to obtain a more realistic estimate of rotavi-
rus incidence among hospitalized children. We used mod-
eling of the 11 years of registry data as well as indirect 
estimates from similar rotavirus disease burden studies. 
Finally, we used these estimates to assess the extent of 




The NPR contains information on hospitalizations for 
all reasons except psychiatric in Denmark since January 
1977, including outpatient treatments since 1995. Infor-
mation on date of admission, date of discharge, diagnoses, 
surgical procedures, and personal identiﬁ  cation number is 
recorded for every hospitalized patient. Diagnoses were 
classiﬁ  ed according to the World Health Organization In-
ternational Classiﬁ  cation of Diseases, version 10 (ICD-10) 
(12). To identify speciﬁ  c rotavirus infections, we extracted 
ICD-10 diagnosis DA080. To compute data on diarrhea, 
we extracted ICD-10 diagnoses DA000 to DA099 (Table).
Data Analyses
From the NPR we extracted information for all Dan-
ish children <5 years of age who were hospitalized during 
January 1994–July 2005 and had diarrheal disease (ICD-10 
codes DA000–DA099) as their primary or secondary di-
agnosis. If several different speciﬁ  c diagnoses of diarrhea, 
together with the nonspeciﬁ  c diagnosis of diarrhea (A099), 
were reported during 1 episode of hospitalization, all the 
different speciﬁ  c diagnoses were counted as unique diag-
noses, whereas the nonspeciﬁ  c diagnosis (A099) was ig-
nored. The nonspeciﬁ  c diagnosis of diarrhea counted as a 
diagnosis only when the hospitalized patient was registered 
as having nonspeciﬁ  c diarrhea. If a person had been admit-
ted for diarrhea several times, only episodes >7 days apart 
were included in the study. For children <2 and <5 years of 
age, we estimated hospitalization incidence rates per 1,000 
person-years at risk by using age- and period-speciﬁ  c per-
son-years at risk in the Danish population.
Other studies, mainly from the United States, have 
demonstrated how many rotavirus-associated hospitaliza-
tions are registered as other types of diarrhea (9,13). To 
achieve a more realistic estimate of the number of rotavirus 
admissions, we applied 2 different approaches based on the 
number of all-cause diarrhea admissions. 
The ﬁ  rst approach was an indirect method known as 
the Brandt estimation method (14), which uses external in-
formation on the proportion of rotavirus admissions among 
all-cause diarrhea admissions. In this approach, the month-
ly number of rotavirus-associated hospitalizations was esti-
mated by multiplying the monthly number of all-cause di-
arrhea hospitalizations with the month-speciﬁ  c proportion 
of rotavirus infections identiﬁ  ed at a Copenhagen County 
university hospital during 1977–1978 (15).
In the second approach, the number of monthly rotavi-
rus-associated hospitalizations during the rotavirus season 
was estimated as the registered number of all-cause diar-
rhea admissions minus the expected level on the basis of the 
much lower average level of all-cause diarrhea admissions 
outside the season. The expected number was estimated by 
using a log-linear Poisson regression model; the dependent 
variable was the monthly number of all-cause diarrhea ad-
missions outside the season. A Poisson regression model 
was used because the monthly number of hospitalizations 
traditionally can be assumed to be Poisson distributed. The 
log-linear regression form means that the logarithm of the 
mean parameter for the dependent variable is modeled by a 
linear combination of the independent variables. Two fac-
tors were included in the model as independent variables. 
Table. Diarrhea-associated hospitalizations, by cause, for children  5 years of age, Denmark, 1994–2004* 
Hospitalizations






mo. of age  % Boys 
Etiology unspecified
 Presumed  infectious  A09 22,475  (69.6)  2,043 6.7 67.8 55.9
  Presumed noninfectious  A085 15 (0.1) – – 66.7 46.7
Etiology specified
  Viral, nonspecified  A084, A083  6,916 (21.4)  628 1.9 67.8 54.5
  Norwalk virus and adenovirus  A081, A082  62 (0.2)  6 – 77.4 58.1
 Rotavirus  A080 1,309  (4.1)  119 0.36 79.1 56.4
 Bacterial  A00-A05 1,415  (4.4)  129 0.39 63.5 55.9
   Parasitic  A06, A07  88 (0.3)  8 – 44.3 56.8
Total 32,280  (100)  2,935 8.9 67.8 55.6
*ICD-10, International Classification of Diseases, version 10; –, too few records to analyze. Rotavirus Hospitalizations in Denmark
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The  ﬁ   rst factor took into account the varying monthly 
number of children at risk; this was done by including the 
logarithm of the risk time as a known factor (an offset). 
The second factor was a secular trend to allow for changes 
in the incidence during the study period; this was done by 
including time (months) as a continuous variable. In other 
words, we applied a log-linear Poisson regression model 
with number of all-cause diarrhea admissions as the depen-
dent variable and logarithm of risk and time as indepen-
dent variables. This regression model, based on the level 
outside the rotavirus season, was then used to estimate the 
monthly expected number of all-cause diarrhea admissions 
during the rotavirus season; i.e., the model for outside 
the season was extrapolated to the rotavirus season. The 
monthly observed number minus the expected number of 
all-cause diarrhea admissions during the rotavirus season 
was taken as an estimate of the monthly rotavirus-associ-
ated hospitalizations Estimation was performed within the 
age groups 0, 1, 2, 3, and 4 years and subsequently summed 
to achieve the total for children <5 years. The approach was 
based on 2 assumptions: ﬁ  rst, that all rotavirus-associated 
hospitalizations were registered correctly in the months of 
July through December, when rotavirus is nonseasonal, 
and second, that the excess admissions during the annual 
peak season of diarrhea, January to June, were attributed 
to a pathogen believed to drive the intraseasonal all-cause 
diarrhea hospitalizations. The pathogen in this instance is 
rotavirus because no other gastrointestinal pathogen has yet 
been identiﬁ  ed with the same seasonality.
According to the Danish National Board of Health, the 
price per hospitalization for diarrhea <4 days is US $1,420 
(8,248 Danish krones [DKK] at a November 2006 ex-
change rate of 583 DKK to US $100). If the hospitalization 
is extended >3 days, cost is US $277 (1,608 DKK) per 24 
hours of added stay (16). The costs include all expenditures 
related to the hospitalization (e.g., hospital bed, healthcare 
personnel, diagnostic testing, antimicrobial drugs, rehydra-
tion treatment, and intensive care). The costs are total costs 
and cannot be segregated further into the various above-
listed expenditure categories (16). In Denmark, public hos-
pital healthcare is free of charge. No private alternative is 
available for hospitalization of children with diarrhea.
Results
Epidemiology of All-Cause Diarrhea and Rotavirus-
coded Hospitalizations
We found a total of 32,280 unique diarrhea-associated 
hospitalizations in Denmark among children <5 years of 
age from 1994 through 2004. Slightly more boys (55.4%) 
than girls were hospitalized with diarrhea; median age 
was 16 months. The number of hospitalizations, regard-
less of diarrhea agent, remained relatively constant over 
time (Figure 1). A total of 1,309 admission records (an-
nual average ≈120) contained the rotavirus-speciﬁ  c ICD-
10 code; proportions by sex were 56% boys and 44% girls 
(Table). In children <5 years of age, 79% of admissions for 
rotavirus had occurred before the age of 2, compared with 
only 68% of admissions for all-cause diarrhea. Incidence 
rates of rotavirus-coded admissions peaked twice during 
early childhood, at 7 and 12 months of age (Figure 2).
Viral infections constituted 85% of diarrhea-associated 
hospitalizations for which etiology was speciﬁ  ed (Table). 
When studying the frequency of the main ICD-10 gastro-
intestinal disease categories (bacteria, virus, parasites, and 
presumed infectious) according to month, the seasonality of 
admissions coded as presumed infectious disease and virus 
without etiology each showed a seasonal pattern very simi-
lar to that of rotavirus, whereas admissions due to bacteria 
and parasites showed a more linear pattern throughout the 
year and bacterial infections showed a tendency to peak in 
the late summer and fall months of August through October 
(Figure 3). When comparing the trends for viral admissions 
without speciﬁ  ed pathogen and trends for rotavirus admis-
sions, we observed parallel seasonal trends throughout the 
entire study period (Figure 1). In all, 85% (1,115/1,309) of 
all rotavirus admissions and 63% (4,342/6,916) of nonspec-
iﬁ  ed viral infections occurred from January through June, 
and the monthly numbers of admissions for these disease 
categories during the study period were signiﬁ  cantly cor-
related (Spearman correlation coefﬁ  cient 0.39, p = 0.007).
Estimates of Rotavirus-associated Hospitalizations 
and Direct Medical Costs
Using the Brandt indirect method, we estimated that 
≈840 hospitalizations (28.7% of all diarrhea) annually were 
due to rotavirus. This ﬁ  nding corresponds to ≈2.5 rotavirus-
associated admissions per 1,000 children <5 years of age 
and ≈5.3 per 1,000 children <2 years of age annually. By 
using Poisson regression, we estimated that ≈780 annual 
hospitalizations (≈26.5% of all admissions for diarrhea in 
children) were associated with rotavirus, resulting in ≈2.4 
and ≈4.9 annual rotavirus-associated admissions per 1,000 
Figure 1. Monthly frequency of diarrhea-associated hospitalizations 
of children <5 years of age, Denmark, 1994–2005.RESEARCH
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children <5 years of age and <2 years of age, respectively. 
The estimate was only slightly affected by deﬁ  ning the ro-
tavirus season as January through June. Adding December 
to the season increased the estimate by 24 annual hospital-
izations, and removing June from the season decreased the 
estimate by 8 annual hospitalizations.
During 1994–2004, 82.4% of all-cause diarrhea admis-
sions lasted <3 days (n = 26,586), and 17.6% (n = 5,694) 
lasted >3 days (range 4–30 days). Thus, the median cost 
for an all-cause diarrhea admission was US $1,375 (8,013 
DKK), and total cost for 2,935 annual admissions was 
therefore ≈US $4.6 million (≈27.1 million DKK) per year.
In terms of duration, 63% of rotavirus-associated 
hospitalizations lasted <3 days; 21%, 4–6 days; 9%, 7–13 
days; and 7%, >13 days. By using the Poisson regression 
model estimate of 780 annual rotavirus-associated hospi-
talizations, we found the total direct medical cost of rota-
virus hospitalizations to be ≈US $1.7 million (≈9.9 million 
DKK) per year. By using the indirect method estimate of 
840 annual rotavirus-associated hospitalizations, we found 
the direct medical costs to be US $1.8 million (≈10.4 mil-
lion DKK).
Discussion
A decision to introduce new rotavirus vaccines into 
Denmark and most other European countries is likely to 
be based on a vaccine’s ability to protect against severe 
disease and prevent hospitalizations. Due to a combination 
of underreporting, low prevalence of testing for rotavirus, 
and misclassiﬁ  cation, hospital episode statistics are rarely 
sufﬁ  cient for assessment of the extent of national rotavi-
rus-associated disease. Studies from the United Kingdom 
(17) and United States that used hospital discharge data 
have shown how the proportion of children coded with the 
speciﬁ  c rotavirus disease code often represents a gross un-
derestimate (18). These observations can be explained in 
part by the combination of poorly deﬁ  ned criteria at most 
hospitals for requesting rotavirus testing and the fact that 
physicians’ diagnostic objective is often differentiation be-
tween the nosocomial highly active transmitting rotavirus 
and other less infectious agents for the purpose of isolation 
rather than therapeutic choices.
Our age-speciﬁ  c analyses demonstrated the magnitude 
of severe rotavirus infections among infants and young 
toddlers and showed disease peaks at 7 and 12 months of 
age. We believe the ﬁ  rst peak is related to waning maternal 
antibody levels and the second peak to daycare attendance 
by Danish children (an effect of crowding and highly infec-
tious transmissible environments).
Studies of seasonal trends of diarrhea-associated hos-
pitalizations have shown that hospitalizations coded as di-
arrhea of nonspeciﬁ  ed viral origin as well as diarrhea of 
presumed infectious origin have a marked winter peak, 
which suggests incomplete registration of rotavirus admis-
sions. Our 2 different models estimated the annual rotavi-
rus-associated hospitalizations to be between 780 and 840. 
We ﬁ  nd it likely that the true contribution by rotavirus to 
all diarrhea-admissions is somewhere in between these 
numbers—or even higher, as the study from the late 1970s 
showed that rotavirus was identiﬁ  ed among 37% of chil-
dren admitted at a major Danish county hospital (15). A 
more recent estimate suggests that rotavirus infection con-
stitutes an even higher proportion of diarrhea cases, ≈60% 
during the rotavirus seasonal months of December through 
April, but these data are based on a limited sample size 
of 69 (11). An updated prospective study of rotavirus and 
other diarrhea pathogens among children in Denmark is 
needed to further specify this estimate.
Despite underreporting and misclassiﬁ  cation of rota-
virus cases that results in gross underestimation of rotavi-
rus disease, the coding of rotavirus diagnosis is relatively 
Figure 2. Incidence of rotavirus-coded hospitalizations in children     
<5 years of age, Denmark, 1994–2005.
Figure 3. Seasonality of diarrhea-associated hospitalizations of 
children <5 years of age, Denmark, 1994–2005. Rotavirus Hospitalizations in Denmark
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stable over time. The NPR system could be used as a timely 
and relatively sensitive tool by which to monitor the effec-
tiveness of rotavirus vaccines. However, doing so would 
require improvements such as complete registrations of ro-
tavirus infections, validation of diagnoses, and implemen-
tation of national guidelines for rotavirus sample collecting 
and testing.
A routine, universal rotavirus immunization program 
with a vaccine that is 75% effective against infection would 
prevent ≈45,000 cases of diarrhea annually among Danish 
children. If effectiveness were 95% against hospitalization, 
≈700–800 hospitalizations could potentially be avoided 
per year, resulting in direct medical cost savings of ≈US 
$1.6 million. This estimate includes neither the number of 
nosocomial transmissions or outpatient visits prevented nor 
the indirect costs incurred when parents are forced to stay 
home from work to take care of sick children, factors that in 
western societies are likely more inﬂ  uential than the prob-
lem of hospitalization alone (19). Weighing the health ben-
eﬁ  ts of vaccination against its costs requires a measure like 
quality-adjusted life years, which takes both reduced illness 
and death into account, and subsequent cost-effectiveness 
analyses in which the healthcare-associated as well as the 
societal costs are considered. 
Our study provides updated information on the extent 
of disease and the cost of diarrhea- and rotavirus-speciﬁ  c 
hospitalizations in a European country. These data are of-
ten requested by health ofﬁ  cials (20) to help increase the 
awareness of rotavirus disease in Europe and help health 
ofﬁ  cials assess the potential beneﬁ  ts of disease prevention 
through vaccination.
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